[EN] SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS<br/>[FR] COMPOSÉS PYRAZOLO[1,5-A]PYRIMIDINE SUBSTITUÉS UTILISÉS COMME INHIBITEURS DE MTOR
申请人:ARRAY BIOPHARMA INC
公开号:WO2011029027A1
公开(公告)日:2011-03-10
Compounds of Formula I: and salts thereof in which R1, R2, R2a, R3, n, X and ring B have the meanings given in the specification, are inhibitors of mTOR and are useful in the treatment of diseases which are sensitive to inhibition of mTOR, such as cancers.
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
申请人:Andrews Steven W.
公开号:US20120178715A1
公开(公告)日:2012-07-12
Compounds of Formula I: and salts thereof in which R
1
, R
2
, R
2a
, R
3
, n, X and ring B have the meanings given in the specification, are inhibitors of mTOR and are useful in the treatment of diseases which are sensitive to inhibition of mTOR, such as cancers.
The combination of Ph4SbI and Bu3SnI proved to be a new excellent catalyst for effecting cycloaddition reaction of inactive 2,3-disubstituted oxiranes with isocyanates under neutral conditions, yielding oxazolidinones in high yields, while either of both metal iodides had no activity individually.